chr4-38831401-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_006068.5(TLR6):​c.-64-1864T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.127 in 152,204 control chromosomes in the GnomAD database, including 2,291 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.13 ( 2291 hom., cov: 32)

Consequence

TLR6
NM_006068.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.36

Publications

1 publications found
Variant links:
Genes affected
TLR6 (HGNC:16711): (toll like receptor 6) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This receptor functionally interacts with toll-like receptor 2 to mediate cellular response to bacterial lipoproteins. A Ser249Pro polymorphism in the extracellular domain of the encoded protein may be associated with an increased of asthma is some populations.[provided by RefSeq, Jan 2011]
TLR1 (HGNC:11847): (toll like receptor 1) The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. They recognize pathogen-associated molecular patterns (PAMPs) that are expressed on infectious agents, and mediate the production of cytokines necessary for the development of effective immunity. The various TLRs exhibit different patterns of expression. This gene is ubiquitously expressed, and at higher levels than other TLR genes. Different length transcripts presumably resulting from use of alternative polyadenylation site, and/or from alternative splicing, have been noted for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.282 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006068.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR6
NM_006068.5
MANE Select
c.-64-1864T>C
intron
N/ANP_006059.2
TLR6
NM_001394553.1
c.-64-1864T>C
intron
N/ANP_001381482.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TLR6
ENST00000508254.6
TSL:1 MANE Select
c.-64-1864T>C
intron
N/AENSP00000424718.2
TLR6
ENST00000381950.2
TSL:6
c.-64-1864T>C
intron
N/AENSP00000371376.1
TLR1
ENST00000506146.5
TSL:4
c.-353+25360T>C
intron
N/AENSP00000423725.1

Frequencies

GnomAD3 genomes
AF:
0.127
AC:
19327
AN:
152086
Hom.:
2295
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.286
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.173
Gnomad ASJ
AF:
0.0821
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.177
Gnomad FIN
AF:
0.0129
Gnomad MID
AF:
0.158
Gnomad NFE
AF:
0.0266
Gnomad OTH
AF:
0.125
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.127
AC:
19339
AN:
152204
Hom.:
2291
Cov.:
32
AF XY:
0.131
AC XY:
9740
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.286
AC:
11865
AN:
41484
American (AMR)
AF:
0.173
AC:
2642
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0821
AC:
285
AN:
3472
East Asian (EAS)
AF:
0.275
AC:
1424
AN:
5178
South Asian (SAS)
AF:
0.178
AC:
856
AN:
4822
European-Finnish (FIN)
AF:
0.0129
AC:
137
AN:
10600
Middle Eastern (MID)
AF:
0.153
AC:
45
AN:
294
European-Non Finnish (NFE)
AF:
0.0266
AC:
1812
AN:
68026
Other (OTH)
AF:
0.124
AC:
263
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
758
1516
2274
3032
3790
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
210
420
630
840
1050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0786
Hom.:
144
Bravo
AF:
0.144
Asia WGS
AF:
0.231
AC:
801
AN:
3474

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.0
DANN
Benign
0.50
PhyloP100
1.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5743792; hg19: chr4-38833022; API